NeuroOne Medical Technologies
NMTC
37 hedge funds and large institutions have $9.44M invested in NeuroOne Medical Technologies in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
9% more funds holding
Funds holding: 34 → 37 (+3)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
0.69% less ownership
Funds ownership: 4.8% → 4.12% (-0.69%)
26% less capital invested
Capital invested by funds: $12.8M → $9.44M (-$3.36M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$143K |
| 2 |
Renaissance Technologies
New York
|
+$53.5K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$49.5K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$38K |
| 5 |
Squarepoint
New York
|
+$36.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$927K |
| 2 |
AIC
AWM Investment Company
New York
|
-$815K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$123K |
| 4 |
VF
Virtu Financial
New York
|
-$88K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47.3K |
NMTC Hedge Fund Activity: Q4 2025 in Review
37 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q4 2025, worth a combined $9.44M — down 26% from $12.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NMTC positions and 5 closed out — a net gain of 3 holders — while 9 added to existing stakes and 9 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $143K. The largest seller was Sio Capital Management, cutting an estimated $927K.
- 37 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q4 2025, up from 34 in Q3 2025.
- Funds reported $9.44M of NeuroOne Medical Technologies stock for Q4 2025, down 26% quarter-over-quarter.
- 8 funds opened new NeuroOne Medical Technologies positions in Q4 2025 and 5 closed out, a net change of +3 holders.
- The largest NeuroOne Medical Technologies buyer in Q4 2025 was Essex Investment Management, an estimated $143K added.
- The largest NeuroOne Medical Technologies seller in Q4 2025 was Sio Capital Management, an estimated $927K sold.
Based on aggregated 13F filings for Q4 2025.